A meta‐analysis demonstrated a significant association between VEGFR‐TKI therapy and increased risk of peripheral neuropathy [50], potentially attributable to the neuroprotective effects of VEGF in promoting axonal growth in dorsal root ganglia (DRG) and protecting DRG neurons from neuronal stress [51, 52]. Here, KDR is linked to peripheral neuropathy.